CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shan, B.
Right arrow Articles by Lee, W. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shan, B.
Right arrow Articles by Lee, W. H.

Cell Growth & Differentiation, Vol 7, Issue 6 689-697, Copyright © 1996 by American Association of Cancer Research


ARTICLES

The molecular basis of E2F-1/DP-1-induced S-phase entry and apoptosis

B Shan, AA Farmer and WH Lee
Center for Molecular Medicine/Institute of Biotechnology, University of Texas Health Science Center at San Antonio 78245, USA.

The transcription factor E2F plays a critical role in the G1 to S transition. E2F is a heterodimer formed by members of the E2F and DP families of DNA-binding proteins. Ectopic expression of E2F-1, the first member of the E2F family identified, is sufficient to cause quiescent cells to enter S phase. Thus, the biological significance of the interaction of E2F-1 with its DP protein partner, DP-1, was unclear. Here, we report on the role of DP-1 in the mediation of E2F-induced S-phase entry and apoptosis. Cells inducible for DP-1, E2F-1, or both were established and characterized. Ectopic expression of DP-1 alone fails to promote cell cycle entry, even when the potent transactivation domain of human papillomavirus-VP16 is fused to the DNA-binding domain of DP-1. In contrast, coexpression of DP-1 and E2F-1 results in greater loss of G1 regulation and significantly more apoptosis than does E2F-1 alone. Using clones co-inducible for DP-1 and E2F-1, expression of potential target genes of E2F activity that may account for its ability to induce S-phase entry was also examined. Induction of E2F-1/DP-1 resulted in increased expression and activity of cyclins A and E, as well as CDK2, prior to S-phase entry. Cyclin D and CDK4, however, were not induced. Phosphorylation of the retinoblastoma protein is also increased following induction of E2F-1/DP-1, suggesting that E2F can feed-back on the retinoblastoma protein, presumably through activation of cyclin A- and/or E-associated kinase activity.


This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
C. Zhang, K. Lundgren, Z. Yan, M. E. Arango, S. Price, A. Huber, J. Higgins, G. Troche, J. Skaptason, T. Koudriakova, et al.
Pharmacologic properties of AG-012986, a pan-cyclin-dependent kinase inhibitor with antitumor efficacy
Mol. Cancer Ther., April 1, 2008; 7(4): 818 - 828.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
S. V. Sharma and J. Settleman
Oncogene addiction: setting the stage for molecularly targeted cancer therapy
Genes & Dev., December 15, 2007; 21(24): 3214 - 3231.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
S. A. Vorburger, N. Hetrakul, W. Xia, M. Wilson-Heiner, N. Mirza, R. E. Pollock, B. Feig, S. G. Swisher, and K. K. Hunt
Gene therapy with E2F-1 up-regulates the protein kinase PKR and inhibits growth of leiomyosarcoma in vivo
Mol. Cancer Ther., November 1, 2005; 4(11): 1710 - 1716.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
F. I. Raynaud, S. R. Whittaker, P. M. Fischer, S. McClue, M. I. Walton, S. E. Barrie, M. D. Garrett, P. Rogers, S. J. Clarke, L. R. Kelland, et al.
In vitro and In vivo Pharmacokinetic-Pharmacodynamic Relationships for the Trisubstituted Aminopurine Cyclin-Dependent Kinase Inhibitors Olomoucine, Bohemine and CYC202
Clin. Cancer Res., July 1, 2005; 11(13): 4875 - 4887.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
J. H. Lieman, L. A. Worley, and J. W. Harbour
Loss of Rb-E2F Repression Results in Caspase-8-mediated Apoptosis through Inactivation of Focal Adhesion Kinase
J. Biol. Chem., March 18, 2005; 280(11): 10484 - 10490.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
M. L. Spencer, M. Theodosiou, and D. J. Noonan
NPDC-1, a Novel Regulator of Neuronal Proliferation, Is Degraded by the Ubiquitin/Proteasome System through a PEST Degradation Motif
J. Biol. Chem., August 27, 2004; 279(35): 37069 - 37078.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. R. Whittaker, M. I. Walton, M. D. Garrett, and P. Workman
The Cyclin-dependent Kinase Inhibitor CYC202 (R-Roscovitine) Inhibits Retinoblastoma Protein Phosphorylation, Causes Loss of Cyclin D1, and Activates the Mitogen-activated Protein Kinase Pathway
Cancer Res., January 1, 2004; 64(1): 262 - 272.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
D. Ma, P. Zhou, and J. W. Harbour
Distinct Mechanisms for Regulating the Tumor Suppressor and Antiapoptotic Functions of Rb
J. Biol. Chem., May 23, 2003; 278(21): 19358 - 19366.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. Farhana, M. Dawson, A. K. Rishi, Y. Zhang, E. Van Buren, C. Trivedi, U. Reichert, G. Fang, M. W. Kirschner, and J. A. Fontana
Cyclin B and E2F-1 Expression in Prostate Carcinoma Cells Treated with the Novel Retinoid CD437 Are Regulated by the Ubiquitin-mediated Pathway
Cancer Res., July 1, 2002; 62(13): 3842 - 3849.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
R. Halaban, E. Cheng, Y. Smicun, and J. Germino
Deregulated E2f Transcriptional Activity in Autonomously Growing Melanoma Cells
J. Exp. Med., March 20, 2000; 191(6): 1005 - 1016.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
O. Loughran and N. B. La Thangue
Apoptotic and Growth-Promoting Activity of E2F Modulated by MDM2
Mol. Cell. Biol., March 15, 2000; 20(6): 2186 - 2197.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Yamano, T. Tokino, M. Yasuda, M. Kaneuchi, M. Takahashi, Y. Niitsu, K. Fujinaga, and T. Yamashita
Induction of Transformation and p53-Dependent Apoptosis by Adenovirus Type 5 E4orf6/7 cDNA
J. Virol., December 1, 1999; 73(12): 10095 - 10103.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. Padmanabhan, D. S. Park, L. A. Greene, and M. L. Shelanski
Role of Cell Cycle Regulatory Proteins in Cerebellar Granule Neuron Apoptosis
J. Neurosci., October 15, 1999; 19(20): 8747 - 8756.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. M. Ojala, M. Tiainen, P. Salven, T. Veikkola, E. Castanos-Velez, R. Sarid, P. Biberfeld, and T. P. Makela
Kaposi's Sarcoma-associated Herpesvirus-encoded v-Cyclin Triggers Apoptosis in Cells with High Levels of Cyclin-dependent Kinase 6
Cancer Res., October 1, 1999; 59(19): 4984 - 4989.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
K. W. Kohn
Molecular Interaction Map of the Mammalian Cell Cycle Control and DNA Repair Systems
Mol. Biol. Cell, August 1, 1999; 10(8): 2703 - 2734.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
P. A. Kirkham, E. W.-F. Lam, H.-H. Takamatsu, R. Michael, and E. Parkhouse
Transcription Factor E2F Controls the Reversible {gamma}{delta} T Cell Growth Arrest Mediated Through WC1
J. Immunol., August 15, 1998; 161(4): 1630 - 1636.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
E. W.- F. Lam, M. S. K. Choi, J. van der Sman, S. A. Burbidge, and G. G. B. Klaus
Modulation of E2F Activity via Signaling through Surface IgM and CD40 Receptors in WEHI-231 B Lymphoma Cells
J. Biol. Chem., April 17, 1998; 273(16): 10051 - 10057.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
J K Hsieh, S Fredersdorf, T Kouzarides, K Martin, and X Lu
E2F1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction.
Genes & Dev., July 15, 1997; 11(14): 1840 - 1852.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1996 by the American Association of Cancer Research.